Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Supplying Peptides for ISB's Human Proteome Atlas


Thermo Fisher announced this week that it would be supplying up to 100,000 synthetic peptides to the Institute for Systems Biology to aid ISB's ongoing effort to map the human proteome.

The project, known as the Human Proteome MRMAtlas, will use the Thermo Fisher peptides in identifying at least four proteotypic peptides for each human protein, which will allow researchers to develop selected-reaction monitoring and multiple-reaction monitoring mass spectrometry assays for each of the roughly 25,000 human proteins.

Thermo Fisher will also be providing ISB with its custom HeavyPeptide AQUA standards to enable researchers to measure the abundance of the natural peptides and to develop precise quantitative SRM/MRM assays.

Headed by Robert Moritz, associate professor and proteomics director at ISB, and Ruedi Aebersold, a professor of molecular systems biology at the Swiss Federal Institute of Technology and the University of Zurich, the project launched in October of last year with $2.7 million in direct funding provided under the American Recovery and Reinvestment Act of 2009 and €2.7 million ($4.1 million) in funding from the European Research Council.

Thermo Fisher is the latest of several companies ISB has announced partnerships with as part of the MRMAtlas project. At the project's outset last year, ISB announced that it would be collaborating with Agilent, using the company's 6460 triple-quadrupole LC-MS/MS and 6530 quadrupole time-of-flight LC-MS platforms (PM 10/23/2009).

Earlier this month, OriGene Technologies announced it would be providing ISB with 5,000 full-length human proteins that researchers could analyze to complement the MRMAtlas work done with synthetic peptides (PM 5/14/2010).

Thermo Fisher is also collaborating with Michael MacCoss, assistant professor at the University of Washington's Department of Genome Sciences, on a similar MRM mass spec database. MacCoss is using the company's Pierce Human In Vitro Protein Expression kits to generate proteins for compiling the database and developing the MRM assays on Thermo Scientific TSQ Vantage machines. (PM 5/21/2010).

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.